N-ω-Hydroxy-L-norarginine

Name: N-ω-Hydroxy-L-norarginine | 189302-40-7
Brand: US-CATO
SKU: S57CPTD787083_10_MG
Price: 19998.0 USD
Availability: OutOfStock

Cat. No S57CPTD787083_10_MG

Vendor: US-CATO

Product Information

Product Name

N-ω-Hydroxy-L-norarginine

Brand Name

US-CATO

Product Number

CPTD787083

CAS

189302-40-7

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

446124

IUPAC Name

(2S)-2-amino-4-amino-(hydroxyamino)methylideneaminobutanoic acid

InChI Key

KOBHCUDVWOTEKO-VKHMYHEASA-N

SMILES

C(CN=C(N)NO)C@@H(C(=O)O)N

References Data Source From Pubchem

TTD: Therapeutic Target Database describing target druggability information

Publication Name: Nucleic Acids Research

Publication Date: 2023-09-15

DOI: 10.1093/nar/gkad751

Glycosylated, Lipid-Binding, CDR-Like Domains of SARS-CoV-2 ORF8 Indicate Unique Sites of Immune Regulation

Publication Name: Microbiology Spectrum

Publication Date: 2023-08-17

DOI: 10.1128/spectrum.01234-23

Discovery of non-boronic acid Arginase 1 inhibitors through virtual screening and biophysical methods

Publication Name: Bioorganic & Medicinal Chemistry Letters

Publication Date: 2023-03-15

DOI: 10.1016/j.bmcl.2023.129193

Chemical similarities and differences among inhibitors of nitric oxide synthase, arginase and dimethylarginine dimethylaminohydrolase-1: Implications for the design of novel enzyme inhibitors modulating the nitric oxide pathway

Publication Name: Bioorganic & Medicinal Chemistry

Publication Date: 2022-10-15

DOI: 10.1016/j.bmc.2022.116970

If small molecules immunotherapy comes, can the prime be far behind?

Publication Name: European Journal of Medicinal Chemistry

Publication Date: 2021-06-05

DOI: 10.1016/j.ejmech.2021.113356

N-ω-Hydroxy-L-norarginine

Product Information

General Information

References Data Source From Pubchem

TTD: Therapeutic Target Database describing target druggability information

Glycosylated, Lipid-Binding, CDR-Like Domains of SARS-CoV-2 ORF8 Indicate Unique Sites of Immune Regulation

Discovery of non-boronic acid Arginase 1 inhibitors through virtual screening and biophysical methods

Chemical similarities and differences among inhibitors of nitric oxide synthase, arginase and dimethylarginine dimethylaminohydrolase-1: Implications for the design of novel enzyme inhibitors modulating the nitric oxide pathway

If small molecules immunotherapy comes, can the prime be far behind?